A recent study suggests that patients who stop using popular GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds much more quickly than those who end traditional lifestyle regimens.
Findings released in a major health publication shows that while overweight people often shed a large proportion of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Users buying such treatments should be aware of the danger of fast rebound weight gain when the medication ends," warns expert Dr. Susan Jebb.
This pace of recovery implies a reversion to pre-treatment mass in about a year and a half.
Analyzing Therapies
The research, which looked at dozens of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with older methods.
The team note that people who lose weight through diet and exercise generally experience a slower weight regain—around 100 grams monthly—after stopping.
The Reason for the Quick Rebound
Experts suggest the way of the injections is key to understanding the amplified weight return.
These medications imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Artificially providing the hormone levels far above than the body's typical production might result in the system to produce less of its endogenous hormone, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making excessive eating much more probable."
A Lifelong Disease?
Medical guidelines suggest the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Many experts say that, given the high risk of weight regain, the treatment might need to be long-term.
This perspective is reinforced by drug manufacturers, who say that the results "highlight the chronic nature of excess weight," comparing it to managing conditions like high blood pressure.
Patient Testimonies
Individuals who have discontinued the medication explain a intense return of hunger.
"I experienced something that goes on and you're instantly extremely hungry," described one woman.
This difficulty is worsened if patients have not developed lasting lifestyle or habit modifications during treatment.
Significant Interest
Recent estimates show that a significant number of people in the UK have used these injections in the last 12 months, with interest being substantial.
- Use is higher among women than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone solution and lasting health benefits likely depends on ongoing lifestyle management.
